Physiomics Plc (AIM:PYC)
London · Delayed Price · Currency is GBP · Price in GBX 0.5000
-0.0250 (-4.76%)
Jun 16, 2026, 11:55 AM GMT
Physiomics Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 0.95 | 0.78 | 0.54 | 0.6 | 0.83 | 0.7 |
Other Revenue | 0.06 | 0.05 | 0.03 | 0.01 | 0.07 | 0.03 |
| 1.01 | 0.83 | 0.57 | 0.61 | 0.9 | 0.73 | |
Revenue Growth (YoY) | 85.81% | 46.20% | -5.81% | -32.75% | 23.23% | -13.16% |
Cost of Revenue | 1.52 | 1.27 | 1.22 | 1.16 | 1.24 | 1.04 |
Gross Profit | -0.51 | -0.44 | -0.65 | -0.55 | -0.34 | -0.31 |
Selling, General & Admin | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Operating Income | -0.53 | -0.46 | -0.67 | -0.57 | -0.36 | -0.34 |
Interest Expense | - | - | -0 | - | - | - |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | -0 | -0 |
EBT Excluding Unusual Items | -0.53 | -0.46 | -0.67 | -0.57 | -0.36 | -0.34 |
Gain (Loss) on Sale of Assets | - | - | -0 | 0 | - | - |
Pretax Income | -0.53 | -0.46 | -0.67 | -0.57 | -0.36 | -0.34 |
Income Tax Expense | -0.05 | -0.04 | -0.06 | -0.09 | -0.11 | -0.12 |
Net Income | -0.49 | -0.42 | -0.61 | -0.48 | -0.25 | -0.22 |
Net Income to Common | -0.49 | -0.42 | -0.61 | -0.48 | -0.25 | -0.22 |
Shares Outstanding (Basic) | 290 | 238 | 135 | 97 | 97 | 97 |
Shares Outstanding (Diluted) | 290 | 238 | 135 | 97 | 97 | 97 |
Shares Change (YoY) | 72.43% | 75.94% | 38.95% | 0.05% | 0.25% | 31.75% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Free Cash Flow | -0.47 | -0.55 | -0.57 | -0.27 | -0.36 | -0.05 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Gross Margin | -50.89% | -52.16% | -113.94% | -91.11% | -37.41% | -42.95% |
Operating Margin | -52.91% | -54.59% | -117.48% | -94.65% | -39.81% | -46.09% |
Profit Margin | -48.13% | -49.78% | -106.80% | -78.79% | -28.10% | -29.53% |
Free Cash Flow Margin | -46.63% | -65.94% | -99.10% | -44.55% | -39.83% | -6.67% |
EBITDA | -0.52 | -0.45 | -0.66 | -0.56 | -0.35 | -0.32 |
EBITDA Margin | -51.91% | -53.51% | -115.91% | -92.93% | -38.57% | -44.39% |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
EBIT | -0.53 | -0.46 | -0.67 | -0.57 | -0.36 | -0.34 |
EBIT Margin | -52.91% | -54.59% | -117.48% | -94.65% | -39.81% | -46.09% |
Revenue as Reported | 1.01 | 0.83 | 0.57 | 0.61 | 0.9 | 0.73 |